An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid

Journal of Immunological Methods

Volumn 296, Issue 1-2, 2005, Pages 179-185

  Van Geel, W J A ^a   Rosengren, L E ^b   Verbeek, M M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain damage; Cerebrospinal fluid; Immunoassay; Neurofilament light chain

Indexed keywords

NEUROFILAMENT PROTEIN;

ARTICLE; AXONAL INJURY; BRAIN INJURY; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; LIGHT CHAIN; NEUROFILAMENT; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

BRAIN DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOENZYME TECHNIQUES; NEUROFILAMENT PROTEINS;

EID: 12944302593     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.11.015     Document Type: Article

References (19)

1. R.P. Berger, M.C. Pierce, S.R. Wisniewski, P.D. Adelson, R.S. Clark, R.A. Ruppel, and P.M. Kochanek Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children Pediatrics 109 2002 2E31
2. D.A. Carpenter, and W. Ip Neurofilament triplet protein interactions: evidence for the preferred formation of NF-L-containing dimers and a putative function for the end domains J. Cell Sci. 109 Pt. 10 1996 2493
3. G. Franz, R. Beer, A. Kampfl, K. Engelhardt, E. Schmutzhard, H. Ulmer, and F. Deisenhammer Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury Neurology 60 2003 91457
4. B. Holmberg, L. Rosengren, J.E. Karlsson, and B. Johnels Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease Mov. Disord. 13 1998 170
5. A. Kay, A. Petzold, M. Kerr, G. Keir, E. Thompson, and J. Nicoll Temporal alterations in cerebrospinal fluid amyloid beta-protein and apolipoprotein E after subarachnoid hemorrhage Stroke 34 2003 12e240
6. K.J. Lamers, B.G. van Engelen, F.J. Gabreels, O.R. Hommes, G.F. Borm, and R.A. Wevers Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders Acta Neurol. Scand. 92 1995 3247
7. J.N. Lycke, J.E. Karlsson, O. Andersen, and L.E. Rosengren Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis J. Neurol. Neurosurg. Psychiatry 64 1998 3402
8. N. Norgren, L. Rosengren, and T. Stigbrand Elevated neurofilament levels in neurological diseases Brain Res. 987 2003 125
9. K. Nylen, J.E. Karlsson, C. Blomstrand, A. Tarkowski, E. Trysberg, and L.E. Rosengren Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis J. Neurosci. Res. 67 2002 6844
10. L. Persson, H.G. Hardemark, J. Gustafsson, G. Rundstrom, I. Mendel-Hartvig, T. Esscher, and S. Pahlman S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system Stroke 18 1987 5911
11. A. Petzold, G. Keir, A.J. Green, G. Giovannoni, and E.J. Thompson A specific ELISA for measuring neurofilament heavy chain phosphoforms J. Immunol. Methods 278 2003 12179
12. L.E. Rosengren, J.E. Karlsson, J.O. Karlsson, L.I. Persson, and C. Wikkelso Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF J. Neurochem. 67 1996 52013
13. M. Sjogren, L. Rosengren, L. Minthon, P. Davidsson, K. Blennow, and A. Wallin Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD Neurology 54 2000 101960
14. M. Sjogren, M. Blomberg, M. Jonsson, L.O. Wahlund, A. Edman, K. Lind, L. Rosengren, K. Blennow, and A. Wallin Neurofilament protein in cerebrospinal fluid: a marker of white matter changes J. Neurosci. Res. 66 2001 3510
15. M. Sjogren, H. Vanderstichele, H. Agren, O. Zachrisson, M. Edsbagge, C. Wikkelso, I. Skoog, A. Wallin, L.O. Wahlund, J. Marcusson, K. Nagga, N. Andreasen, P. Davidsson, E. Vanmechelen, and K. Blennow Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values Clin. Chem. 47 2001 101776
16. M. Tullberg, L. Rosengren, E. Blomsterwall, J.E. Karlsson, and C. Wikkelso CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus Neurology 50 1998 41122
17. M. Tullberg, L. Hultin, S. Ekholm, J.E. Mansson, P. Fredman, and C. Wikkelso White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination Acta Neurol. Scand. 105 2002 6417
18. B.G. van Engelen, K.J. Lamers, F.J. Gabreels, R.A. Wevers, W.J. van Geel, and G.F. Borm Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid Clin. Chem. 38 1992 6813
19. P.E. Vos, K.J. Lamers, J.C. Hendriks, M. van Haaren, T. Beems, C. Zimmerman, W. van Geel, H. de Reus, J. Biert, and M.M. Verbeek Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury Neurology 62 2004 81303